Literature DB >> 10100587

Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency.

A Toren1, A Nagler, N Amariglio, Y Neumann, H Golan, B Bilori, C Kaplinsky, M Mandel, M Biniaminov, M Levanon, E Rosenthal, J Davidson, F Brok-Simoni, G Rechavi.   

Abstract

A 2-month-old girl with severe combined immunodeficiency (SCID), presented with mild staphylococcal skin infection, lymphopenia, low T cell number, absence of B cells, high number of NK cells, and a negligible response to mitogens. Since her older brother died as a result of SCID 2 years earlier, cord blood was harvested from a sister born 2 1/2 years earlier, who was normal and fully matched both by serology and molecular typing. In view of her clinical condition and in spite of a high number of NK cells with normal activity, HUCBT without preparative conditioning was performed. No G-CSF was administered. Engraftment with mixed chimerism was evident 3 weeks post transplantation. There were no peritransplantation complications. Eighteen months post transplantation, the girl is in excellent condition, blood counts are normal, T cell engraftment is complete, B cell engraftment is proceeding gradually, and the mitogen stimulation tests are normal. Due to the unique nature of HUCB hematopoietic cells, engraftment without conditioning may be possible in patients with SCID with fully matched donors. This is the first HUCBT performed without conditioning.

Entities:  

Mesh:

Year:  1999        PMID: 10100587     DOI: 10.1038/sj.bmt.1701578

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  1 in total

1.  Long-term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice.

Authors:  Piotr Walczak; Ning Chen; David Eve; Jennifer Hudson; Tanja Zigova; Juan Sanchez-Ramos; Paul R Sanberg; Cyndy D Sanberg; Alison E Willing
Journal:  Brain Res Bull       Date:  2007-07-10       Impact factor: 4.077

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.